DK0632053T3 - Cykliske adhæsionsinhibitorer - Google Patents
Cykliske adhæsionsinhibitorerInfo
- Publication number
- DK0632053T3 DK0632053T3 DK94104396T DK94104396T DK0632053T3 DK 0632053 T3 DK0632053 T3 DK 0632053T3 DK 94104396 T DK94104396 T DK 94104396T DK 94104396 T DK94104396 T DK 94104396T DK 0632053 T3 DK0632053 T3 DK 0632053T3
- Authority
- DK
- Denmark
- Prior art keywords
- lys
- alanine
- asp
- atoms
- prodn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
- Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4310643A DE4310643A1 (de) | 1993-04-01 | 1993-04-01 | Cyclische Adhäsionsinhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0632053T3 true DK0632053T3 (da) | 2000-03-13 |
Family
ID=6484433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94104396T DK0632053T3 (da) | 1993-04-01 | 1994-03-21 | Cykliske adhæsionsinhibitorer |
Country Status (20)
Country | Link |
---|---|
US (2) | US5849692A (da) |
EP (1) | EP0632053B1 (da) |
JP (1) | JP3694332B2 (da) |
KR (1) | KR100304201B1 (da) |
CN (1) | CN1056851C (da) |
AT (1) | ATE184288T1 (da) |
AU (1) | AU684489B2 (da) |
CA (1) | CA2120303C (da) |
CZ (1) | CZ286768B6 (da) |
DE (2) | DE4310643A1 (da) |
DK (1) | DK0632053T3 (da) |
ES (1) | ES2138632T3 (da) |
GR (1) | GR3032074T3 (da) |
HU (1) | HUT69726A (da) |
NO (1) | NO313756B1 (da) |
PL (1) | PL178791B1 (da) |
RU (1) | RU2130030C1 (da) |
SK (1) | SK281828B6 (da) |
TW (1) | TW343198B (da) |
UA (1) | UA34436C2 (da) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753230A (en) | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
DE4415310A1 (de) * | 1994-04-30 | 1995-11-02 | Merck Patent Gmbh | Cyclopeptide |
US7053041B1 (en) | 1996-05-31 | 2006-05-30 | The Scripps Research Institute | Methods and compositions useful for inhibition of αvβ5mediated angiogenesis |
DE19534016A1 (de) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Biotinderivate |
DE19534177A1 (de) * | 1995-09-15 | 1997-03-20 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
DE19538741A1 (de) * | 1995-10-18 | 1997-04-24 | Merck Patent Gmbh | Cyclopeptidderivate |
DE19613933A1 (de) * | 1996-04-06 | 1997-10-09 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
RU2194528C2 (ru) | 1996-05-31 | 2002-12-20 | Дзе Скриппс Рисерч Инститьют | Способы и композиции, используемые для ингибирования ангиогенеза |
DE19736772A1 (de) * | 1997-08-23 | 1999-02-25 | Merck Patent Gmbh | Cyclopeptidderivate |
JP2002533404A (ja) | 1998-12-23 | 2002-10-08 | ジー・ディー・サール・アンド・カンパニー | 新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法 |
UA71608C2 (en) | 1999-03-11 | 2004-12-15 | Merck Patent Gmbh | A method for producing the cyclic pentapeptide |
DE19933173A1 (de) | 1999-07-15 | 2001-01-18 | Merck Patent Gmbh | Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ |
US6359015B1 (en) | 2000-02-28 | 2002-03-19 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for antagonizing inhibition effects of alcohol on cell adhesion |
US6624187B1 (en) * | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
DE10040105A1 (de) | 2000-08-17 | 2002-02-28 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften |
FR2814744B1 (fr) * | 2000-10-04 | 2002-11-29 | Commissariat Energie Atomique | Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese |
CN1507354A (zh) * | 2001-03-02 | 2004-06-23 | ͨ��ҽ�ƹ�˾ | 通过给予整合蛋白αvβ3拮抗剂并与其它预防或治疗药剂配合来预防或者治疗炎性疾病或自身免疫疾病的方法 |
US7879267B2 (en) * | 2001-08-02 | 2011-02-01 | J&J Vision Care, Inc. | Method for coating articles by mold transfer |
EP1487489A4 (en) * | 2002-03-04 | 2008-10-01 | Medimmune Inc | METHODS FOR PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN AVB3 ANTAGONIST ASSOCIATED WITH HMG-COA REDUCTASE INHIBITOR OR BISPHOSPHONATE |
CA2478239A1 (en) * | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
AU2003226065B2 (en) * | 2002-04-12 | 2009-02-26 | Ludwig Institute For Cancer Research, Ltd | Recombinant anti-interleukin-9 antibodies |
GB0217017D0 (en) * | 2002-07-23 | 2002-08-28 | Bioacta Ltd | Peptide 2 |
ITRM20020402A1 (it) * | 2002-07-29 | 2004-01-29 | Sigma Tau Ind Farmaceuti | Derivati fluoro-alchil-ciclopeptidi ad attivita' anti-integrine. |
US6977272B2 (en) * | 2002-10-16 | 2005-12-20 | President And Fellows Of Harvard College | Method for antagonizing inhibition effects of alcohol on cell adhesion |
WO2004066956A2 (en) * | 2003-01-30 | 2004-08-12 | Medimmune, Inc. | Uses of integrin alphavbeta3 antagonists |
WO2004091510A2 (en) * | 2003-04-11 | 2004-10-28 | Medimmune, Inc. | Recombinant il-9 antibodies and uses thereof |
US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
ITRM20040239A1 (it) * | 2004-05-13 | 2004-08-13 | Sigma Tau Ind Farmaceuti | Derivati ciclopeptidici ad attivita' antintegrine. |
AU2005299355A1 (en) | 2004-10-27 | 2006-05-04 | Medimmune, Llc | Modulation of antibody specificity by tailoring the affinity to cognate antigens |
WO2008008373A2 (en) | 2006-07-11 | 2008-01-17 | Arubor Corp | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
WO2008021237A1 (en) | 2006-08-10 | 2008-02-21 | Arubor Corporation | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors |
RU2500685C2 (ru) | 2006-11-10 | 2013-12-10 | Кара Терапеутикс, Инк | Синтетические пептидные амиды |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
WO2009124754A1 (en) * | 2008-04-08 | 2009-10-15 | Merck Patent Gmbh | Compositions containing cyclic peptides and methods of use |
EP2358737B1 (en) | 2008-10-23 | 2017-03-01 | Steba Biotech S.A. | Rgd-containing peptidomimetics and uses thereof |
CN101906141B (zh) * | 2009-06-02 | 2013-04-17 | 首都医科大学 | 一类肽链与双脂肪醇链的偶联物及其制备方法和应用 |
CN101906144B (zh) * | 2009-06-03 | 2013-06-19 | 首都医科大学 | 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用 |
RU2626002C1 (ru) | 2016-10-24 | 2017-07-21 | Общество С Ограниченной Ответственностью "Айвикс" | Новая группа пептидов для лечения женской сексуальной дисфункции |
RU2655763C2 (ru) * | 2016-10-24 | 2018-05-29 | Общество С Ограниченной Ответственностью "Айвикс" | Фармацевтическая композиция и способ лечения женских сексуальных дисфункций |
US10494403B2 (en) | 2018-03-06 | 2019-12-03 | Ciphore Biomed Technology Limited Company | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4472305A (en) * | 1983-05-17 | 1984-09-18 | Sterling Drug Inc. | Hexapeptide amides |
JP2945680B2 (ja) * | 1988-09-09 | 1999-09-06 | 旭硝子株式会社 | ペプチド誘導体およびその用途 |
US5192746A (en) * | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
JPH04264097A (ja) * | 1991-02-16 | 1992-09-18 | Asahi Glass Co Ltd | ペプチド誘導体およびその用途 |
HUT63609A (en) * | 1992-03-10 | 1993-09-28 | Sandoz Ag | Process for producing new derivatives and isosters of beta-amino acids and pharmaceutical compositions comprising such compounds |
UA43823C2 (uk) * | 1992-07-06 | 2002-01-15 | Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
-
1993
- 1993-04-01 DE DE4310643A patent/DE4310643A1/de not_active Withdrawn
-
1994
- 1994-03-02 UA UA94005107A patent/UA34436C2/uk unknown
- 1994-03-21 DE DE59408715T patent/DE59408715D1/de not_active Expired - Lifetime
- 1994-03-21 EP EP94104396A patent/EP0632053B1/de not_active Expired - Lifetime
- 1994-03-21 AT AT94104396T patent/ATE184288T1/de active
- 1994-03-21 ES ES94104396T patent/ES2138632T3/es not_active Expired - Lifetime
- 1994-03-21 DK DK94104396T patent/DK0632053T3/da active
- 1994-03-25 CZ CZ1994704A patent/CZ286768B6/cs not_active IP Right Cessation
- 1994-03-29 NO NO19941152A patent/NO313756B1/no not_active IP Right Cessation
- 1994-03-30 CA CA002120303A patent/CA2120303C/en not_active Expired - Lifetime
- 1994-03-30 AU AU59185/94A patent/AU684489B2/en not_active Expired
- 1994-03-30 CN CN94103298A patent/CN1056851C/zh not_active Expired - Lifetime
- 1994-03-30 TW TW083102761A patent/TW343198B/zh active
- 1994-03-31 RU RU94011276A patent/RU2130030C1/ru active
- 1994-03-31 JP JP09682994A patent/JP3694332B2/ja not_active Expired - Lifetime
- 1994-03-31 HU HU9400937A patent/HUT69726A/hu unknown
- 1994-03-31 KR KR1019940006639A patent/KR100304201B1/ko not_active IP Right Cessation
- 1994-03-31 PL PL94302854A patent/PL178791B1/pl unknown
- 1994-03-31 SK SK383-94A patent/SK281828B6/sk unknown
-
1996
- 1996-03-15 US US08/616,770 patent/US5849692A/en not_active Expired - Lifetime
-
1998
- 1998-10-01 US US09/164,585 patent/US6169072B1/en not_active Expired - Lifetime
-
1999
- 1999-12-08 GR GR990403165T patent/GR3032074T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100304201B1 (ko) | 2001-11-30 |
CZ70494A3 (en) | 1995-01-18 |
DE4310643A1 (de) | 1994-10-06 |
NO941152L (no) | 1994-10-03 |
EP0632053A2 (de) | 1995-01-04 |
JPH06329698A (ja) | 1994-11-29 |
UA34436C2 (uk) | 2001-03-15 |
NO313756B1 (no) | 2002-11-25 |
SK281828B6 (sk) | 2001-08-06 |
ES2138632T3 (es) | 2000-01-16 |
ATE184288T1 (de) | 1999-09-15 |
TW343198B (en) | 1998-10-21 |
CZ286768B6 (en) | 2000-07-12 |
SK38394A3 (en) | 1995-02-08 |
US6169072B1 (en) | 2001-01-02 |
DE59408715D1 (de) | 1999-10-14 |
CA2120303A1 (en) | 1994-10-02 |
US5849692A (en) | 1998-12-15 |
CN1099760A (zh) | 1995-03-08 |
CN1056851C (zh) | 2000-09-27 |
GR3032074T3 (en) | 2000-03-31 |
RU2130030C1 (ru) | 1999-05-10 |
HUT69726A (en) | 1995-09-28 |
HU9400937D0 (en) | 1994-06-28 |
EP0632053B1 (de) | 1999-09-08 |
JP3694332B2 (ja) | 2005-09-14 |
AU684489B2 (en) | 1997-12-18 |
PL178791B1 (pl) | 2000-06-30 |
NO941152D0 (no) | 1994-03-29 |
AU5918594A (en) | 1994-10-06 |
CA2120303C (en) | 2007-05-01 |
EP0632053A3 (de) | 1995-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59408715D1 (de) | Cyclische Adhäsionsinhibitoren | |
CA1315479C (en) | Platelet-aggregation inhibitor peptide derivatives | |
US5023233A (en) | Fibrinogen receptor antagonists | |
ES2144179T3 (es) | Inhibidores de adhesion ciclicos. | |
US5061693A (en) | Fibrinogen receptor antagonists | |
ZA943464B (en) | Vascular endothelial growth factor 2 | |
EP0410540A1 (en) | Fibrinogen receptor antagonists | |
CA2027315A1 (en) | Fibrinogen receptor antagonists | |
KR930007972A (ko) | 환상 혈관활성 펩티드 | |
KR920009846A (ko) | 시클로펩티드 | |
DK0585397T3 (da) | Bombesinanaloger | |
KR880001696A (ko) | 레닌 억제용 디- 및 트리 펩타이드 및 이의 제조방법 | |
NO941151L (no) | Lineære adhesjonsinhibitorer | |
DK0393934T3 (da) | Nye peptider samt antidemensmidler indeholdende disse peptider | |
NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
DK1309613T3 (da) | Farmaceutisk præparat omfattende et analgetisk peptid | |
EP0182627A3 (en) | Basic v1-vasopressin antagonists | |
NO975565L (no) | Benstimulerende faktor | |
ES8701784A1 (es) | Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina | |
Fressinaud et al. | Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen | |
DK0552106T3 (da) | Peptider med antagonistaktivitet over for bradykinin | |
KR960703612A (ko) | 면역계 및 중추 신경계 치료용 신규의 트리펩티드(novel tripeptides useful in immune and cns therapy) | |
EP0791350A3 (de) | Mittel zur dauerhaften Verformung von menschlichen Haaren | |
SI0789761T1 (en) | Human scf, a splice variant thereof, its pharmaceutical use | |
KR940011479A (ko) | 시클로 펩티드 |